Efficacy of Magnetic Imaging Colonoscopy Applied to Beginner Endoscopists
NCT ID: NCT05746962
Last Updated: 2023-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
128 participants
INTERVENTIONAL
2023-03-06
2024-10-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Narrow Band Imaging With or Without Magnifying Colonoscopy
NCT01577875
Computer-aided Detection for Colonoscopy
NCT03842059
The Usefulness of I-scan in Screening Colonoscopy
NCT01417611
Effect of Magnetic Endoscopic Imaging on Patient Pain During Colonoscopy
NCT02681692
Safety and Efficacy of the NaviAid™ G-Eye System During Colonoscopy
NCT01749722
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group that does not use the scopeguide screen
The control group should remove the looping of colonoscope by looking at the general colonoscopy screen The control group cannot use scopeguide screen Scopeguide screen is blinded by an opaque wrapping paper
ScopeGuide Navigated Colonoscope
colonoscopes equipped with ScopeGuide
Group using the scopeguide screen
The experimental group uses a general endoscopic image during colonoscopic insertion The experimental group should remove the looping of colonoscope by looking at the scopeguide screen
ScopeGuide Navigated Colonoscope
colonoscopes equipped with ScopeGuide
Navigation screen
ScopeGuide's 3D visualisation screen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ScopeGuide Navigated Colonoscope
colonoscopes equipped with ScopeGuide
Navigation screen
ScopeGuide's 3D visualisation screen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* the patient who visit to examine the colonoscopy
Exclusion Criteria
* the patient who has electronic devices in the body
* bowel obstruction and bleeding
* glomerulus filter rate \< 30
* inflammatory bowel disease, pregnancy
* previous history of bowel resection and abdominal surgery
* who refuse to write the informed consent
* previous history of allergic reaction to sedative drugs and beans, egg
* SBP \<80, SpO2\<90
19 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Korea University Anam Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Keum, Bo Ra
Professor of Division of Gastroenterology and Hepatology, Department of Internal Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Han Jo Jeon
Seoul, Seong Buk Gu, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022AN0126
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.